TrialThe British journal of dermatology2019

Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.

Y W Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.